Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: subsequent events

"On June 4, 2013, we issued 760,000 stock options from our 2006 Stock Option Plan with an exercise price of $0.12 to our employees and directors. The options vested immediately upon issuance."

I don't care if they gain as long as I gain too from an increased share price. That is part of normal business.

Looking forward to "the plan" once we win.

Share
New Message
Please login to post a reply